Immunai vs Parallel Bio
Immunai
Mapping the Immune System with AI to Improve Health
171 employees · est. 2019 · New York, United States
Parallel Bio
Using the immune system to cure disease
27 employees · est. 2021 · Watertown, United States
Immunai is the older company (2019 vs 2021); Immunai is the larger of the two.
4 signals in the last 90 days
Side-by-Side Comparison
| Metric | Immunai | Parallel Bio |
|---|---|---|
| Founded | ||
| Founded | 2019 older | 2021 |
| Headquarters | ||
| Headquarters | New York, United States | Watertown, United States |
| Employees | ||
| Employees | 171 larger | 27 |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Health and Wellness, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series B | Series A |
| Total Funding | ||
| Total Funding | $300.50M | $25.43M |
| Funding Rounds | ||
| Funding Rounds | 5 | 4 |
| Services | ||
| Services | Target Discovery, Preclinical Evaluation, Clinical Trial Optimization, Data Generation, Data Augmentation, Compute and Validate Therapeutic Insights, Recommendation Engine | Human-first Drug Discovery, Precision Medicine Solutions, Foundation Model Development, Biological Atlas Creation |
| Target Customers | ||
| Target Customers | biopharmaceutical companies, research institutions, pharma companies | Pharmaceutical Companies, Biotech Firms, Research Institutions, Healthcare Providers |
| Taxonomy | ||
| Taxonomy | Immune System MappingSingle-cell GenomicsBiotechTherapeutic DiscoveriesDrug DevelopmentPatient Outcomes +8 | Immune System OrganoidsDrug DiscoveryImmunotherapy DevelopmentComputational BiologyBiotechnology InnovationHuman Health Insights +8 |
| Website | ||
| Website | immunai.com | parallel.bio |
About Immunai
Immunai, founded in 2019, is a United States-based startup that is revolutionizing the Biotechnology and Pharmaceutical industries with its innovative approach. The company's slogan, "Mapping the Immune System with AI to Improve Health," reflects its mission to map and decode the immune system using...
About Parallel Bio
Parallel Bio is a promising startup founded in 2021, aiming to revolutionize the field of drug discovery with its innovative technology. The company has developed a groundbreaking platform described as a human 'immune system in a dish', which holds the potential to significantly improve the efficien...
Also comparing in this category
Comparing more than these two?
Get Immunai, Parallel Bio and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Immunai compare?
A PDF of Immunai and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Immunai with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Immunai on 3 Aug 2026, and Parallel Bio on 4 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
